article thumbnail

Klotho : A hope for the acute kidney injury-diabetes comorbidity


Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, India. Klotho : A hope for the acute kidney injury-diabetes comorbidity. Thu, 11/24/2022 - 10:12. About Authors. Ajinath Kale, Anil Bhanudas Gaikwad*.

article thumbnail

With overdoses skyrocketing, Congress must consider non-opioid alternatives to pain management

MedCity News

Yet, they are too often overlooked by Congress and a healthcare system that tends to default to pharmacological treatments as the first step in pain reduction. Complementary and integrative healthcare providers, including chiropractic physicians, acupuncturists, and massage therapists, provide effective and safe treatments for pain.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Channels Identified as Possible Pharmacological Targets for Kidney Potassium Handling

Pharmacy Times

Next-generation research shows that targeting specific Kir channels, which regulate salt reabsorption in the kidneys, could improve diuretic function in kidney patients.

article thumbnail

Click Therapeutics kicks off digital therapy remote trial for migraine

Pharmaceutical Technology

Digital therapy is becoming prevalent as a viable treatment path for companies seeking to increase treatment accessibility by reducing barriers that accompany pharmacological interventions. Its use is especially applicable in mental health and neurology.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.

article thumbnail

Can GLP-1 obesity therapy restore NK cell function?

European Pharmaceutical Review

NK cell functionality was restored in participants following gold-standard pharmacological obesity GLP-1 analogue treatment, according to a study published in Obesity. This may contribute to the benefits reported with these medications in people with obesity, the data showed.

article thumbnail

NICE to update endometriosis guidelines to improve diagnosis and surgical management

Pharmaceutical Technology

For many women, pharmacological treatment options do not provide adequate symptomatic relief, and often result in considerable side effects, including menopause-like symptoms and decreases in bone mineral density. However, NICE stated it will further explore new approaches to address these unmet needs during scoping of the update.